Wendy Miller

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Kenneth J. Valenzano, Laykea Tafesse, Gary Lee et al. · Neuropharmacology · 2005 · 282 citations

Cannabis Use, Molecular Pharmacology, Pain Research +12

Novel, Potent ORL-1 Receptor Agonist Peptides Containing α-Helix-Promoting Conformational Constraints

Chongwu Zhang, Wendy Miller, Kenneth J. Valenzano et al. · Journal of Medicinal Chemistry · 2002 · 46 citations · Full text

Analysis of 9-fluorenylmethoxycarbonyl (FMOC) loading of solid-phase synthesis resins by gas chromatography

William S. Newcomb, Tracy L. Deegan, Wendy Miller et al. · Biotechnology and Bioengineering · 1998 · 22 citations

Engineering, Fmoc-bearing Compounds, Supercritical Fluid Chromatography +17

1,3-Dihydro-2,1,3-benzothiadiazol-2,2-diones and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones as ligands for the NOP receptor

R. Richard Goehring, John F. Whitehead, Kevin Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 19 citations · Full text

Functional Selectivity, Medicine, Receptor (Biochemistry) +5

Design and parallel synthesis of piperidine libraries targeting the nociceptin (N/OFQ) receptor

Zhengming Chen, Wendy Miller, Shen Shan et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 18 citations · Full text

Piperidine Libraries, Medicinal Chemistry, Biochemistry +14